Eco1-dependent cohesin acetylation anchors chromatin loops and cohesion to define functional meiotic chromosome domains
Abstract
Cohesin organizes the genome by forming intra-chromosomal loops and inter-sister chromatid linkages. During gamete formation by meiosis, chromosomes are reshaped to support crossover recombination and two consecutive rounds of chromosome segregation. Here we show that meiotic chromosomes are organised into functional domains by Eco1 acetyltransferase-dependent positioning of both chromatin loops and sister chromatid cohesion in budding yeast. Eco1 acetylates the Smc3 cohesin subunit in meiotic S phase to establish chromatin boundaries, independently of DNA replication. Boundary formation by Eco1 is critical for prophase exit and for the maintenance of cohesion until meiosis II, but is independent of the ability of Eco1 to antagonize the cohesin-release factor, Wpl1. Conversely, prevention of cohesin release by Wpl1 is essential for centromeric cohesion, kinetochore monoorientation and co-segregation of sister chromatids in meiosis I. Our findings establish Eco1 as a key determinant of chromatin boundaries and cohesion positioning, revealing how local chromosome structuring directs genome transmission into gametes.
Data availability
Sequencing data has been deposited in GEO under accessions as below:* GSE185021 is the reference Series for your publication:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185021* This SuperSeries record provides access to all of your data and is thebest accession to be quoted in any manuscript discussing the data. Forinformation on GEO linking and citing, please refer to:https://www.ncbi.nlm.nih.gov/geo/info/linking.html.* You may also cite the SubSeries that are linked to GSE185021:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185016https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185017https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185018https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185019https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185020
Article and author information
Author details
Funding
Wellcome Trust (107827)
- Rachael E Barton
- Lucia F Massari
- Adèle L Marston
Wellcome Trust (220780)
- Lucia F Massari
- Adèle L Marston
Wellcome Trust (102316)
- Rachael E Barton
Wellcome Trust (203149)
- Rachael E Barton
- Lucia F Massari
- Daniel Robertson
- Adèle L Marston
Biotechnology and Biological Sciences Research Council (BB/S018018/1)
- Rachael E Barton
- Lucia F Massari
- Adèle L Marston
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2022, Barton et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,227
- views
-
- 342
- downloads
-
- 18
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.
-
- Cell Biology
- Developmental Biology
A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.